Literature DB >> 1489180

Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice.

M L van Ogtrop1, H Mattie, B R Sekh, E van Strijen, R van Furth.   

Abstract

The efficacies of ciprofloxacin and ampicillin against Listeria monocytogenes in an immunosuppressed mouse model of listeriosis were compared. Immunosuppression was achieved by administration of 2.5 mg of hydrocortisone acetate daily. Both ciprofloxacin and ampicillin were effective in reducing the number of viable L. monocytogenes cells in the liver and spleen. After treatment with 100 mg of ampicillin per kg of body weight every 6 h for 3 days, virtually no L. monocytogenes could be recovered from the livers and spleens of the mice. In contrast, after treatment with 100 mg of ciprofloxacin per kg every 6 h for 3 days, a geometric mean of 5 x 10(4) CFU of L. monocytogenes was recovered from the spleens and 1 x 10(5) CFU was recovered from the livers of the mice. Results of the study show that the antibacterial efficacy of ampicillin is far superior to that of ciprofloxacin in our animal model of listeriosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489180      PMCID: PMC284338          DOI: 10.1128/AAC.36.11.2375

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Changes in white blood cell counts after administration of cortisone acetate to healthy ambulatory individuals.

Authors:  H J KOWALSKI; W E REYNOLDS; D D RUTSTEIN
Journal:  J Lab Clin Med       Date:  1952-12

Review 2.  Molecular determinants of Listeria monocytogenes pathogenesis.

Authors:  D A Portnoy; T Chakraborty; W Goebel; P Cossart
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  The relative potency of amoxycillin and ampicillin in vitro and in vivo.

Authors:  H Mattie; G B van der Voet
Journal:  Scand J Infect Dis       Date:  1981

4.  Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages.

Authors:  M B Carlier; B Scorneaux; A Zenebergh; J F Desnottes; P M Tulkens
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

5.  Rapid determination of amoxycillin (clamoxyl) and ampicillin (penbritin) in body fluids of many by means of high-performance liquid chromatography.

Authors:  T B Vree; Y A Hekster; A M Baars; E Van der Kleijn
Journal:  J Chromatogr       Date:  1978-05-01

6.  Synergistic effect of human lysozyme plus ampicillin or beta-lysin on the killing of Listeria monocytogenes.

Authors:  V Asensi; J Fierer
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

7.  Uptake of ciprofloxacin by human neutrophils.

Authors:  C S Easmon; J P Crane
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

8.  Uptake of ciprofloxacin by macrophages.

Authors:  C S Easmon; J P Crane
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

Review 9.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 10.  Antimicrobial drugs, microorganisms, and phagocytes.

Authors:  P J van den Broek
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr
View more
  7 in total

Review 1.  Listeria Monocytogenes infections.

Authors:  R C Gordon
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

2.  An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics.

Authors:  Carlos A Rodriguez; Maria Agudelo; Javier M Gonzalez; Omar Vesga; Andres F Zuluaga
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

3.  Monitoring of resistance genes in Listeria monocytogenes isolates and their presence in the extracellular DNA of biofilms: a case study from the Czech Republic.

Authors:  Martina Boháčová; Kamila Zdeňková; Zuzana Tomáštíková; Viviana Fuchsová; Kateřina Demnerová; Renáta Karpíšková; Jarmila Pazlarová
Journal:  Folia Microbiol (Praha)       Date:  2018-04-21       Impact factor: 2.099

4.  Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes.

Authors:  C Michelet; J L Avril; C Arvieux; C Jacquelinet; N Vu; F Cartier
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

5.  Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis.

Authors:  Yan Li; Xizhong Cui; Xuemei Li; Steven B Solomon; Robert L Danner; Steven M Banks; Yvonne Fitz; Djillali Annane; Charles Natanson; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

6.  Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cells.

Authors:  T Nichterlein; M Kretschmar; C Budeanu; J Bauer; W Linss; H Hof
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

7.  A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone.

Authors:  Ivone Jimenez-Toro; Carlos A Rodriguez; Andres F Zuluaga; Julian D Otalvaro; Omar Vesga
Journal:  PLoS One       Date:  2020-12-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.